NCT06811623Completed
Omentopexy After Sleeve Gastrectomy in Children and Adolescences.
Omentopexy After Sleeve Gastrectomy in Children and Adolescences, is it Effective in Reducing Post-operative Complications.
Source: ClinicalTrials.gov · Last updated 6 Feb 2025
Brief summary (registry, in English)
Laparoscopic sleeve gastrectomy (LSG) is a restrictive bariatric operation, has become one of the most commonly performed bariatric surgeries. Postoperative gastrointestinal complications are agonizing in patients underwent this procedure. Most of these complications can be prevented by omentopexy in association with sleeve gastrectomy. The Primary aim of this study to assess the effectiveness of omentopexy during laparoscopic sleeve gastrectomy in reducing post-operative complication.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 48 (actual)
- First submitted
- 26 Jan 2025
- Start date
- 1 Jan 2015
- Primary completion date
- 1 Oct 2024
- Lead sponsor
- Mohammad Daboos
- Diseases
- Obesity
- NCT number
- NCT06811623
What you commit to
- Study type: Interventional
- Participants enrolled: 48
- From 1 Jan 2015 to the primary completion date, 1 Oct 2024
- No sites listed in no country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- previous operation
Other
- secondary obesity
- more than 18 years
Who the study is looking for
- body mass index (BMI) of 40 kg/m2 or
- BMI of 35 kg/m2 due to at least 1 comorbid condition
Age in the registry: 6 years to 8 years · Sex: All · Does not accept healthy volunteers
This page is information, not medical advice. Discuss any trial with your doctor.